SecBot SecBot
PRESS-RELEASE ·Filed Jul 20, 2026

COSM

Cosmos Health Inc.
BULLISH
Impact 4/10
Horizonweeks Processed3mo ago WireGlobeNewswire
Press release · Contract
Actionable Insight ▲ Bullish

Monitor subsequent quarterly filings for actual revenue contribution from the Albanian expansion. The partnership appears incremental but lacks material financial disclosure — further deals or revenue guidance would be needed to significantly re-rate the stock.

DirectionBullish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
COSM ▲ +66.26% at T+60d
LONG call ✓ call won +66.26% · α vs SPY +61.42% · entry $0.2303 → $0.3829
Entry = T+0 close
Jul 20, 2026
via day close
T+1d
-9.08%
call -9.08% · α -9.91%
$0.2094
settled 3mo ago
T+5d
-13.20%
call -13.20% · α -12.77%
$0.1999
settled 3mo ago
T+20d
-10.99%
call -10.99% · α -15.11%
$0.2050
settled 2mo ago
T+60d
+66.26%
call +66.26% · α +61.42%
$0.3829
settled 14d ago

Price Chart

Loading chart...

Executive Summary

Cosmos Health expands its Sky Premium Life distribution partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units and projected annualized orders exceeding 54,000 units. The expansion builds on an April 2025 launch, but no financial impact or revenue contribution is disclosed.

Key Facts

  • Partnership with Pharma Cell expanded for Sky Premium Life brand in Albania
  • Average monthly orders already exceeding 4,500 units
  • Projected annualized orders exceeding 54,000 units
  • Products distributed across Albania, recommended by doctors and healthcare professionals
  • Original partnership launched in April 2025

Financial Impact

No financial figures disclosed; projected annual order volume of 54,000+ units but revenue per unit not stated

revenueunit volume

Risk Factors

  • Projected order volumes may not materialize or convert to meaningful revenue
  • No disclosed pricing or margin data to assess profitability impact
  • Forward-looking statements subject to execution risk and market conditions

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3330080
33 reports for COSM
Performance horizon
60% Hit rate @ T+20 3 of 5 directional calls Went positive at some point 6 of 7 best @ T+60▲ +41.38%Apr 24, 2026
Filters
Rows
Reports for COSM — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
8-K
BULLISH ★ 6/10
$0.2530awaiting T+20—$0.2360 (−6.72%)
Oct 16, 2026
10d ago
SC 13G/A
NEUTRAL ★ 3/10
$0.3250awaiting T+20—$0.2360 (−27.38%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$0.3496awaiting T+20—$0.2360 (−32.49%)
Sep 3, 2026
7w ago
Press Release
BEARISH ★ 6/10
$0.2660 $0.4300▼ −61.65%▼ −62.77%$0.2360 (+11.28%)
Aug 19, 2026
9w ago
Press Release
BEARISH ★ 6/10
$0.1930awaiting T+20—$0.2360 (−22.28%)
Jul 20, 2026
14w ago
Press Release
BULLISH ★ 4/10
$0.2303 $0.2050▼ −10.99%▼ −15.11%$0.2360 (+2.48%)
Jul 17, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2348 $0.2179▼ −7.20%▼ −11.64%$0.2360 (+0.51%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2807 $0.2065▼ −26.43%▼ −30.05%$0.2360 (−15.92%)
Jul 15, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2785 $0.2071▼ −25.64%▼ −27.98%$0.2360 (−15.26%)
Jul 14, 2026
15w ago
Press Release
NEUTRAL ★ 3/10
$0.3071 $0.2198▼ −28.43%▼ −30.92%$0.2360 (−23.15%)
Showing 10 of 33

US Market Status

Market Closed — Opens Wed (17h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026